Ancient mind-body practice could help you lower your blood pressure

Publicly released:
International
CC:0
CC:0

A traditional Chinese exercise known as baduanjin has been proven to lower people's blood pressure in a recent clinical trial, say Chinese researchers. The practice usually takes 10 to 15 minutes to perform, and involves moving between eight standardised positions that integrate aerobic, isometric, flexibility and mind-body components. To work out its effects on blood pressure, the researchers followed 216 participants over 12 to 52 weeks. For the duration, the participants were randomly assigned to do one of: baduajin, self-directed exercise alone, or brisk walking. The team say, compared to self-directed exercise, practising baduanjin five days a week reduced participants' systolic blood pressure - the top number on your blood pressure reading - by three points in a 24 hour period, and by five points by the end of the study; similar to that of some first-line medications.

News release

From: American College of Cardiology

Ancient Mind-Body Practice Proven to Lower Blood Pressure in Clinical Trial

Study shows traditional Chinese practice comparable to brisk walking and some medication trials at lowering BP

A traditional Chinese mind-body practice that combines slow, structured movement, deep breathing and meditative focus lowered blood pressure as effectively as brisk walking in a large randomized clinical trial published in JACC, the flagship journal of the American College of Cardiology. Blood pressure reductions were seen after three months and sustained for one year.

High blood pressure is one of the leading preventable risk factors for heart disease. Clinical guidelines recommend regular physical activity, yet long-term adherence to exercise programs is challenging for many people, particularly when routines require equipment, dedicated space, gym memberships or ongoing supervision.

Baduanjin is a widely practiced, standardized eight-movement sequence that integrates aerobic, isometric, flexibility and mind–body components. Practiced for centuries and commonly performed in community settings across China, the routine typically takes 10–15 minutes and requires no equipment and only minimal initial instruction, allowing it to be performed in a wide range of settings. Because it is low- to moderate-intensity, it is considered safe and accessible for many adults.

“Given its simplicity, safety and ease at which one can maintain long-term adherence, baduanjin can be implemented as an effective, accessible and scalable lifestyle intervention for individuals trying to reduce their blood pressure,” said Jing Li, MD, PhD, senior author of the study and Director, Department of Preventive Medicine, National Center for Cardiovascular Diseases in Beijing, China.

In the first large, multicenter randomized trial to look at the impact of baduanjin on blood pressure, researchers followed 216 participants across seven communities to determine changes in 24-hour systolic blood pressure from baseline to 12 and 52 weeks. Participants were 40 years old or older and had a systolic blood pressure of 130-139 mm Hg, which according to the ACC/AHA High Blood Pressure Guideline is considered stage 1 hypertension. They were randomly assigned to one of three arms: baduanjin, self-directed exercise alone, or brisk walking for the 52-week intervention.

Compared to self-directed exercise, practicing baduanjin five days a week reduced 24-hour systolic blood pressure approximately 3 mg Hg and office systolic blood pressure by 5 mg Hg at both three months and one year, which is comparable to reductions seen with some first-line medications. Baduanjin showed comparable results and safety profile to brisk walking at one year.

Notably, the benefits were sustained even without ongoing monitoring, a key challenge for many lifestyle interventions that struggle to maintain long-term adherence outside structured programs.

“Baduanjin has been practiced in China for over 800 years, and this study demonstrates how ancient, accessible, low-cost approaches can be validated through high-quality randomized research,” said Harlan M. Krumholz, MD, FACC, Editor-in-Chief of JACC and the Harold H. Hines, Jr Professor at the Yale School of Medicine. “The blood pressure effect size is similar to that seen in landmark drug trials, but achieved without medication, cost or side effects. This makes it highly scalable for community-based prevention, including in resource-limited settings.”

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research American College of Cardiology, Web page The URL will go live after the embargo ends
Journal/
conference:
Journal of the American College of Cardiology
Research:Paper
Organisation/s: National Center for Cardiovascular Diseases, Beijing, China
Funder: The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Media Contact/s
Contact details are only visible to registered journalists.